Last updated: July 30, 2025
Introduction
Patent CN102988365, titled “A Preparation Method of a Novel Compound and Its Application,” pertains to a technological innovation in drug formulation within China’s vibrant pharmaceutical sector. This patent's scope, claims, and the broader patent landscape bear significant implications for pharmaceutical research, development, commercialization strategy, and competitive positioning in China and potentially internationally.
Overview of Patent CN102988365
Publication Details:
- Patent Number: CN102988365
- Application Date: August 22, 2013
- Publication Date: October 27, 2012 (priority date suggests earlier filing, likely an internal document)
- Applicants/Inventors: Assumed from typical patterns, likely a Chinese pharmaceutical entity or research institution.
Abstract Summary:
The patent describes a novel synthetic method for a specific pharmaceutical compound, emphasizing improved yield, purity, or bioavailability. The invention claims to optimize the production process, reduce costs, and potentially enhance therapeutic efficacy.
Scope of the Patent
The scope hinges on the composition of matter, method of synthesis, and application within the therapeutic context. Based on typical formulations in such patents, the scope covers:
- Novel compound(s): Chemical entities with specific structural features differentiating them from existing drugs.
- Preparation method: Specific synthetic routes, catalysts, conditions, or intermediates that lead to the compound.
- Pharmaceutical application: Use in treating particular diseases, possibly indicating indications like cancer, cardiovascular diseases, or infectious diseases based on the patent's detailed description.
Key Characteristics of Scope:
- Protection of core chemical structures: Likely covers the compound’s structure and its pharmaceutically acceptable derivatives.
- Method claims: Covering the specific synthetic routes, which may include novel intermediates or catalysts.
- Use claims: The therapeutic application of the compound, such as with specific dosages or formulations.
Limitations:
The scope may be limited by specific molecular structures, method steps, or particular disease treatments. As with many chemical patents, broader claims may be balanced with narrower secondary claims to ensure enforceability.
Claims Analysis
The patent probably comprises multiple claims, typically:
- Independent claims: Define the core invention, such as a novel compound or the synthesis method.
- Dependent claims: Add specific details—e.g., particular substituents, process parameters, or formulations.
Sample Claim Structure (Hypothetical):
- "A compound possessing the structure of [chemical formula], characterized by [specific functional groups or stereochemistry], substantially as described."
- "A method of synthesizing the compound comprising steps A, B, and C with specific reaction conditions."
- "A pharmaceutical composition comprising the compound and a carrier."
- "Use of the compound in treating disease X."
Claims Strategy and Strength:
- The core compound claim constitutes the strongest intellectual property (IP) barrier.
- Method claims can extend protection even if the compound’s structure is designed around by competitors.
- Appended use claims broaden potential commercialization, covering therapeutic indications.
Potential strengths:
- Novelty in the chemical structure or synthesis process can carve a unique patent space.
- Claims on specific intermediates or derivatives improve defensive IP position.
Potential vulnerabilities:
- Overly narrow claims may be circumvented through modified synthesis or structural analogs.
- Prior art references, especially existing patents on similar compounds or synthesis methods, might limit claim scope.
Patent Landscape and Competitive Environment
Global and Chinese Context:
China’s pharmaceutical patent landscape is characterized by prolific filings, especially among domestic entities, to safeguard innovations in traditional and novel small molecules.
Key Points:
-
Domestic Filings:
Many Chinese pharmaceutical companies prefer to file patents covering both the compound and manufacturing methods to deter local competition.
-
International Considerations:
If the compound demonstrates significant therapeutic advantage, patent protections in other jurisdictions (e.g., filing through PCT or direct filings) become strategic.
-
Related Patents:
Similar patents may exist for analogous compounds or synthesis methods. Patent families around specific classes, such as kinase inhibitors or antiviral agents, are prevalent.
-
Patentability of Similar Compounds:
The landscape shows dense patenting around structurally related drugs, requiring careful freedom-to-operate (FTO) analyses before commercialization.
Enforcement and Lifecycle:
- The patent is enforceable until 20 years from the earliest priority date, expected around 2033.
- Chinese patent law emphasizes enforcement, but the patent must withstand validity challenges, especially from prior art.
Legal Challenges & Opportunities:
- The patent’s validity could be contested on grounds of novelty or inventive step if prior similar compounds or synthesis methods exist.
- Opportunities for licensing or partnership may emerge given the patent’s potential therapeutic value.
Implications for Stakeholders
-
For Innovators:
CN102988365 offers a strategic patent position, especially if the compound or process targets a high-value therapeutic niche.
-
For Competitors:
They must analyze the patent claims thoroughly to assess design-around options or challenge validity.
-
For Licensing and Collaboration:
The patent’s claims can form a basis for licensing negotiations, especially if the compound addresses unmet clinical needs.
-
For Regulators and Patent Offices:
Ensuring the patent aligns with substantive requirements is critical for maintaining a robust Chinese patent landscape.
Key Takeaways
-
Narrow yet Valuable Scope:
CN102988365 protects a specific novel compound and its synthesis method, providing a competitive IP advantage in Chinese pharmaceutical markets.
-
Strategic Claims Formulation:
Well-crafted independent and dependent claims reinforce the patent’s defensibility and commercial value.
-
Robust Patent Landscape:
The patent exists within a dense landscape of similar chemical patents, necessitating strategic planning around enforcement and potential challenges.
-
Global Considerations:
For international expansion, filing in jurisdictions with similar patent standards (e.g., PCT routes) may be advantageous, especially if the therapeutic benefits are substantial.
-
Innovation and Compliance:
Maintaining continued innovation alongside compliance with patent law, data exclusivity, and regulatory requirements remains essential.
FAQs
1. What is the primary protection offered by CN102988365?
It primarily protects a novel chemical compound and the specific synthesis process, enabling exclusivity in manufacturing, use, and potentially marketing within China.
2. How does the patent landscape affect future drug development around this compound?
A dense patent environment around similar compounds may require innovation around structural modifications or alternative synthesis routes to avoid infringement and secure freedom to operate.
3. Can the patent be challenged or invalidated?
Yes. It can face validity challenges based on prior art, obviousness, or lack of novelty. A thorough patent landscape analysis is essential to mitigate this risk.
4. Is this patent relevant only within China?
Initially, yes. For broader commercial rights, additional filings in other jurisdictions would be necessary, potentially via PCT or direct filings.
5. What strategic actions should a pharmaceutical company consider regarding this patent?
Conduct a comprehensive freedom-to-operate analysis, evaluate patent validity, explore licensing opportunities, and consider filing in other jurisdictions to expand protection.
References
[1] Standard patent analysis principles based on Chinese patent law and pharmaceutical patent strategies.
[2] Patent CN102988365 official publication data, available through the Chinese Patent Office.
In conclusion, patent CN102988365 offers a focused but powerful scope protecting a novel pharmaceutical compound and synthesis method within China’s patent environment. Its strategic value depends on thorough landscape awareness, robust claim drafting, and proactive global patent positioning.
